Min CHF:
Max CHF:
  1-30 of 134
Supplier Product name Cat.no. Pack size Price
Rozanolixizumab Biosimilar - Research Grade ICH5051-1MG ICH5051-5MG ICH5051-10MG ICH5051-20MG ICH5051-50MG ICH5051-100MG 276,00 600,00 930,80 1'575,80 2'949,80 3'918,80
Teclistamab Biosimilar - Research Grade ICH5209-1MG ICH5209-5MG ICH5209-10MG ICH5209-20MG ICH5209-50MG ICH5209-100MG 315,00 973,50 1'748,30 2'542,50 4'693,50 7'018,50
Apitegromab Biosimilar - Research Grade ICH5228-1MG ICH5228-5MG ICH5228-10MG ICH5228-20MG ICH5228-50MG 372,80 1'361,30 2'019,80 2'678,30 5'313,80
Sugemalimab Biosimilar - Research Grade ICH5278-1MG ICH5278-5MG ICH5278-10MG ICH5278-20MG ICH5278-50MG 372,80 1'361,30 2'019,80 2'678,30 5'313,80
Zimberelimab Biosimilar - Research Grade ICH5292-1MG ICH5292-5MG ICH5292-10MG ICH5292-20MG ICH5292-50MG 372,80 1'361,30 2'019,80 2'678,30 5'313,80
Anti-CD4 [CE9.1 (Clenoliximab)], Human IgG4, lambda Ab00450-13.0 Ab00450-13.0-BT 550,00 2'170,00
Anti-Bet v 1 [BAB3], Human IgG4, lambda Ab00666-13.0 Ab00666-13.0-BT 550,00 2'170,00
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8], Human IgG4, lambda Ab00104-13.0 Ab00104-13.0-BT 550,00 2'170,00
  1-30 of 134